QC

Ipca now plus Rs.2700 Crores Company is global player with significant presence in over 110 countries with high brand equity in the domestic and international markets
Our manufacturing facilities of bulk drugs at Ratlam have earned accreditations and approvals from the worlds most vigilant regulatory bodies.

Post: QC, Production (api) & Pilot Plant

Comed was in 1986, when a team of experienced and energetic Pharma professionals decided to go big and to do something different and better than routine. A seed was sown: a beginning was made. These young, dynamic and experienced future leaders chose Baroda (Now called Vadodara), the Educational and Pharma capital of Gujarat (Western India) as their base, a choice which itself proved to be big contributing factor for growth.

Walk in interview will be conducted for filling up the following post at Head Office National Rural Health Mission, Haryana purely on contract basis initially up to 31.03.2014 with details as mentioned below: -

Post: Consultant, Quality Manager, Drug Inventory Monitor- 5 Posts

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services.  With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

One of India's most respected Companies, Shree Baidyanath Ayurved Bhawan (p) Ltd. (Kolkata), popularly known as Baidyanath, is the acknowledged leader of Ayurvedic know-how. Established in 1917, the Company has played a pioneering role in re-establishing ancient knowledge with modern research and manufacturing techniques.

Post: Quality Control- Incharge

Saudi Pharmaceutical Industries first and only of its kind manufacturing veterinary and human drugs in Saudi Arabia.
Saudi Pharmaceutical Industries now manufactures high quality veterinary products and its eminence is compared with European standards. During this short period of time we have not only fulfilled the requirements of Saudi Arabia but also expanded our business to all GCC and number of African countries.

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.

While there is a huge opportunity for pharmaceutical and Healthcare companies to sell their products in emerging markets due to rising incomes, higher incidence of chronic and lifestyle diseases, better insurance coverage, and better patent protection regimes for drugs, major roadblocks such as lack of mature distribution networks, lower price points due to generics competition, and counterfeiting are leaving even the large companies struggling to handle the challenges from some of these less sophisticated markets. Local business partnerships and better understanding and responsiveness to cultural differences will be very important in determining the success in emerging markets.

ASSOCHAM in its quest to resolve these issues and create a fine link through global regulators and industry experts, and bring first hand information at the disposal are some of the objectives aimed through ASSOCHAM’s unique endeavour “GCT 2013 ? Challenges & Opportunities”

Participation Details
Due to the support of Department of Biotechnology, Government of India, ASSOCHAM wave off the Registration fees for GCT 2013; Generic Drugs, Clinical Trials & Technology Conference at Hotel Metropole, Ahmedabad on 30th April 2013.